WEBINARS

• WEBINAR: Biomanufacturing Assumes Central Role in Cell and Gene Therapies

  Cell and gene therapy products represent some of the most exciting new drugs that biopharmaceutical companies are looking to bring to market. Based on recent clinical successes, an increasing number […]

• WEBINAR: Preclinical Considerations in Cell and Gene Therapy Product Development

  Presented by Absorption Systems’ Chief Business Officer, Vatsala Naageshwaran About this webinar: In vitro and in vivo preclinical evaluation of cell and gene therapy (CGT) products contributes significantly to characterization […]

• WEBINAR: The ABCs and 123s of the BCS

  The Biopharmaceutics Classification System, or BCS, is a framework for classification of drugs according to two fundamental properties of the drug substance, i.e., permeability and solubility. The BCS class of […]

• WEBINAR: An Advanced Patented Tool to Streamline Formulation Development

  Originally Hosted: Thursday, November 15, 2018 11:30am-12:30pm EST An Advanced Patented Tool to Streamline Formulation Development  Enhanced IVIVC Evaluate Formulations: Bioequivalence, Post Approval Changes, 505(b)(2) Formulations Maximize Therapeutic Outcomes Only […]

• WEBINAR: In Vitro Relative Potency Assays for Commercialization

  Webinar Download Originally Hosted: Wednesday, February 6, 2019 12:30pm-1:00pm EST (30-minutes) In Vitro Relative Potency Assays for Commercialization of Gene Therapy Products Presenter: Karen Doucette, MBA Director of Operations, ACF […]

• WEBINAR: Performance Matrix for Topical Dermatologic Products: Development through Approval

  Webinar Download Originally Hosted: Thursday, March 7, 2019 Performance Matrix for Topical Dermatologic Products: Development through Approval This webinar will cover: Models to Evaluate the Performance of Complex Topical Drug […]

• Webinar: Challenges in Adapting Neutralizing and Anti-Drug Antibody Assays to Gene Therapies

  Webinar Download Originally Hosted: Thursday, October 10, 2019 11:00am – 12:00pm EDT Challenges in Adapting Neutralizing and Anti-Drug Antibody Assays to Gene Therapies This presentation summarizes a recently published whitepaper […]

• Webinar: State of the Art in Clinical Transporter DDI Evaluation

  Webinar Download Originally Hosted: Thursday, June 13, 2019 11:30am – 12:30pm EDT State of the Art in Clinical Transporter DDI Evaluation This presentation summarized the state-of-the-art in transporters in drug […]

• WEBINAR: In Vitro Relative Potency Assays for Commercialization

  What you will learn: Considerations for in vitro potency assay development for AAV products with complex MOA(s) Logistics of transferring an existing potency assay from R&D to GMP Statistical and regulatory insights […]